Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More 3/19/21 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More Analysis and Commentary 6/5/20 Analysis and Commentary 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More Advocacy at a Glance 6/5/20 Advocacy at a Glance 6/5/20 Advocacy at a Glance Read More 11/21/19 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More Advocacy at a Glance 3/16/19 Advocacy at a Glance 3/16/19 Advocacy at a Glance Read More 3/12/19 3/12/19 Sharpless Appointed Acting Commissioner of FDA Read More Advocacy at a Glance 4/20/18 Advocacy at a Glance 4/20/18 Advocacy at a Glance Read More Advocacy at a Glance 2/9/18 Advocacy at a Glance 2/9/18 Advocacy at a Glance Read More Advocacy at a Glance 1/13/18 Advocacy at a Glance 1/13/18 Advocacy at a Glance Read More Advocacy at a Glance 8/20/17 Advocacy at a Glance 8/20/17 Advocacy at a Glance Read More Advocacy at a Glance 5/19/17 Advocacy at a Glance 5/19/17 Advocacy at a Glance Read More Advocacy at a Glance 5/12/17 Advocacy at a Glance 5/12/17 Advocacy at a Glance Read More Advocacy at a Glance 3/11/17 Advocacy at a Glance 3/11/17 Advocacy at a Glance Read More Advocacy at a Glance 2/3/17 Advocacy at a Glance 2/3/17 Advocacy at a Glance Read More Analysis and Commentary 1/6/17 Analysis and Commentary 1/6/17 The Speedy Appointment of a New Commissioner? Read More Older Posts
Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More
Analysis and Commentary 6/5/20 Analysis and Commentary 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More
Analysis and Commentary 1/6/17 Analysis and Commentary 1/6/17 The Speedy Appointment of a New Commissioner? Read More
